Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 5/20 | 1.00 |
| ▸ | SRD5A1 | P18405 | 4/20 | 0.74 |
| ▸ | HTR2C | P28335 | 2/20 | 0.62 |
| ▸ | HTR2B | P41595 | 2/20 | 0.62 |
| ▸ | DRD2 | P14416 | 1/20 | 0.62 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 1/20 | 0.62 |
| ▸ | HTR7 | P34969 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | TTR | P02766 | 1/20 | 0.55 |
| ▸ | PTPRC | P08575 | 2/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29460235 | 1.00 | SRD5A2 (1.00) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| Cyanide SCHEMBL11194392 | 0.95 | SRD5A2 (0.90) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| SCHEMBL31069845 | 0.93 | SRD5A2 (0.86) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| SCHEMBL29709873 | 0.93 | SRD5A2 (0.86) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| SCHEMBL3105349 | 0.93 | SRD5A2 (0.86) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| SCHEMBL16126108 | 0.91 | SRD5A2 (0.84) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| SCHEMBL28119578 | 0.91 | SRD5A2 (0.83) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| SCHEMBL27506 | 0.90 | SRD5A2 (0.81) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| SCHEMBL31456551 | 0.90 | SRD5A2 (0.81) | SRD5A2SRD5A1HTR2CHTR2BDRD2 | |
| SCHEMBL30976964 | 0.89 | SRD5A2 (0.79) | SRD5A2SRD5A1HTR2CHTR2BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108176147-B | Lathe oil mist adsorbs recovery unit | 宁波艾格玛机电科技有限公司 | 2020-08-11 | — | — | CN | claimed |
| US-7842696-B2 | Piperazine derivatives as inhibitors of stearoyl-CoA desaturase | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-11-30 | — | — | US | claimed |
| US-20090221583-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-09-03 | — | — | US | claimed |
| CN-1166704-C | Anti-reflection coating polymer and preparing method thereof | �ִ����Ӳ�ҵ��ʽ���� | 2004-09-15 | — | — | CN | claimed |
| US-6492441-B2 | DIAZONAPTHOQUINONESULFONYL-SUBSTITUTED POLYMER SUITABLE FOR USE IN ANTI-REFLECTIVE COATING OF A SEMICONDUCTOR DEVICE | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2002-12-10 | — | — | US | claimed |
| US-20020120070-A1 | Anti reflective coating polymers and the preparation method thereof | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2002-08-29 | — | — | US | claimed |
| CN-1260355-A | Anti-reflection coating polymer and preparing method thereof | HYUNDAI ELECTRONICS IND (KR) | 2000-07-19 | — | — | CN | claimed |
| US-20250376385-A1 | PEROVSKITE POWDER, LIGHT EMITTING LAYER FOR LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING THE SAME | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2025-12-11 | — | — | US | disclosed |
| US-12479838-B2 | D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-11-25 | — | — | US | disclosed |
| CN-120136251-A | Method for producing hydroxyl free radical by high-efficiency low-energy consumption chemistry | 上海交通大学 | 2025-06-13 | — | — | CN | disclosed |
| US-20240269293-A1 | PROTEIN-MACROMOLECULE CONJUGATES AND METHODS OF USE THEREOF | OD THERAPEUTICS LIMITED (CN) | 2024-08-15 | — | — | US | disclosed |
| EP-4313154-A1 | PROTEIN-MACROMOLECULE CONJUGATES AND METHODS OF USE THEREOF | OD Therapeutics Limited (HK) | 2024-02-07 | — | — | EP | disclosed |
| CN-117355337-A | Protein-macromolecule conjugates and methods of use thereof | 奥迪曼药业科技有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-5182316-A | Forming a UV-detectable fluorophore in a mixture of hydride containing silicone, unsaturated silicone, cationically sensitive compound and a latent dibenzofulvene | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-01-26 | — | — | US | disclosed |
| US-5118559-A | Dibenzofulvene compound | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-06-02 | — | — | US | disclosed |
| WO-1992000995-A1 | CYCLIC CELL ADHESION MODULATION COMPOUNDS | TANABE SEIYAKU CO. LTD. (JP) | 1992-01-23 | — | — | WO | disclosed |
| US-5047444-A | Hydrosilatable polysiloxanes, unsaturated compounds and a dibenzofulvene chromogen; coatings | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0400972-A2 | Fluorescent degree of cure monitors | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4052436-A | ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1977-10-04 | — | — | US | disclosed |
| US-3989841-A | ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269293-A1 | PROTEIN-MACROMOLECULE CONJUGATES AND METHODS OF USE THEREOF | CD44, MACROD1, MSN | SRD5A2 4748/4885SRD5A1 4745/4885HTR2C 3784/4885 |
| US-12479838-B2 | D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof | DRD3, ADRB3, VDR | SRD5A2 704/4885SRD5A1 884/4885HTR2C 78/4885 |
| US-20090221583-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | SCD, SCD5, FADS2 | SRD5A2 594/4885SRD5A1 558/4885HTR2C 3359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.